Tanning injections are commonly associated with Melanotan 2, also written as Melanotan II or MT2. Interest in these products has grown through social media, fitness communities and online discussions, but the terminology can make it difficult to separate established facts from marketing claims and personal reports.
This guide explains what tanning injections are, how Melanotan 2 is understood to affect pigmentation, the current UK regulatory position, reported side effects and the limitations of laboratory testing. It is intended to provide balanced information, not medical advice or a recommendation to use Melanotan 2.
What Are Tanning Injections?
The phrase “tanning injections” usually refers to products containing Melanotan 2, a synthetic peptide related to the naturally occurring hormone alpha-melanocyte-stimulating hormone, often shortened to alpha-MSH.
Alpha-MSH forms part of the body’s pigmentation system. It interacts with melanocortin receptors, including the melanocortin 1 receptor, or MC1R, found on melanocytes. These are the cells responsible for producing melanin, the pigment that contributes to the colour of the skin, hair and eyes.
Melanotan 2 was developed as a laboratory-made melanocortin receptor agonist. Early research found that it could increase skin pigmentation in humans, but it was not subsequently approved as a cosmetic tanning medicine.
For a more detailed explanation of the peptide itself, read What Is Melanotan 2?.
How Does Melanotan 2 Affect Skin Pigmentation?
Melanin is produced inside melanocytes and transferred to nearby skin cells. It helps determine visible skin colour and plays a role in the skin’s response to ultraviolet radiation.
Activation of MC1R can encourage the production of eumelanin, a darker form of melanin. Melanotan 2 is not selective only for MC1R, however. It can interact with several melanocortin receptors, which helps explain why reported effects are not limited to skin pigmentation.
Small early clinical studies reported increased pigmentation after Melanotan 2 was administered under controlled research conditions. Those studies do not establish that unlicensed products obtained outside a regulated medical supply chain are safe, consistent or suitable for cosmetic use.
Individual responses may also vary. Natural skin tone, genetics, MC1R variants, existing freckles and moles, ultraviolet exposure and the actual contents of a product may all influence the result.
Are Tanning Injections Licensed in the UK?
Melanotan 2 is not a licensed medicine for cosmetic tanning in the UK. It has not been authorised by the Medicines and Healthcare products Regulatory Agency, known as the MHRA, as a tanning treatment.
Cancer Research UK states that it is illegal to sell or supply Melanotan injections in the UK. The MHRA has also warned about unauthorised medicines sold online and advises people who experience suspected adverse effects to speak to a healthcare professional and report them through the Yellow Card scheme.
This distinction is important. A product being available online does not mean it has received regulatory approval. Laboratory analysis of a sample does not change the product’s legal status or demonstrate that it is medically safe or effective.
Regulation can change, so readers should check current information directly with the MHRA or another appropriate UK authority rather than relying only on commercial websites.
Tanning Injections, Nasal Sprays and Other Formats
Melanotan 2 is discussed online in both injectable and nasal spray formats. These are different methods of administration, but neither format is an MHRA-authorised cosmetic tanning treatment.
An injectable product bypasses several of the body’s natural barriers and introduces additional risks associated with preparation, contamination and injection. A nasal product avoids an injection, but that does not establish that its contents, absorption, effectiveness or long-term safety have been clinically validated.
Products described as nasal spray kits may also be supplied either as a prepared liquid or as separate components. Our article Should MT2 Nasal Spray Be Pre-Mixed? explains why the storage history of a prepared liquid can be difficult to assess.
Neither format should be presented as risk-free, clinically approved or equivalent to a licensed medicine.
What Side Effects Have Been Reported?
Published research and case reports have described a range of effects associated with Melanotan 2. Reported short-term effects include:
- nausea
- facial or general flushing
- reduced appetite
- tiredness
- yawning and stretching
- dizziness
- spontaneous erections and changes in sexual arousal
- darkening of freckles and existing moles
- uneven or unexpected pigmentation
The available evidence is limited. Some information comes from small early trials conducted under research supervision, while other evidence comes from individual case reports or adverse-event reports. These sources can identify possible safety signals, but they cannot reliably establish how frequently an effect occurs among people using unregulated products.
More serious events have also appeared in case reports, including prolonged erections requiring urgent treatment and systemic illness. A case report cannot prove that every similar event was caused by Melanotan 2, but it can justify caution and further investigation.
Our separate guide to the possible side effects of Melanotan 2 examines the reported effects in more detail.
What About Moles, Freckles and Melanoma?
Pigmentation changes deserve particular attention because Melanotan 2 acts on pathways involved in melanin production. Published case reports have described rapid darkening of existing moles, the appearance of new or atypical-looking moles and melanoma diagnoses following reported Melanotan 2 use.
These reports do not prove that Melanotan 2 directly causes melanoma. In several cases, other important risk factors were present, including sunbed use, ultraviolet exposure or an existing susceptibility to atypical moles. Researchers have therefore cautioned against drawing a simple cause-and-effect conclusion from isolated cases.
The uncertainty should not be interpreted as proof of safety. A substance that changes the appearance of pigmented lesions may also make skin monitoring more difficult. New moles, changes in size, shape or colour, irregular borders, bleeding, itching or a lesion that looks different from surrounding moles should be assessed by a qualified healthcare professional.
The NHS provides current guidance on melanoma symptoms and when to contact a GP.
Does a Darker Tan Protect Against UV Damage?
A darker appearance should not be treated as protection from ultraviolet radiation. Any increase in pigmentation does not make sunbeds or excessive sun exposure safe.
Ultraviolet radiation can damage DNA in skin cells and remains a major risk factor for premature skin ageing and skin cancer. Combining tanning products with sunbeds may increase overall UV exposure, particularly when someone stays in the sun longer because their skin appears less likely to burn.
Sun protection remains important regardless of skin tone or pigmentation changes. This includes avoiding deliberate overexposure, using appropriate sunscreen, covering the skin and checking it regularly for changes.
What Can Independent Laboratory Testing Show?
Independent laboratory analysis can provide useful information about the particular sample submitted for testing. Depending on the methods used, a report may address:
- whether the expected compound was identified
- the measured quantity or content of that sample
- reported purity under the laboratory’s test conditions
- the sample or batch details recorded on the report
However, a laboratory report has important limits. It does not automatically prove:
- that every vial or product is identical to the submitted sample
- sterility, unless an appropriate sterility test was specifically performed
- safety or effectiveness in humans
- suitability for injection or nasal administration
- compliance with medicines regulation
- regulatory approval by the MHRA
- the absence of every possible contaminant
The test method, sample identification, date and scope of analysis should therefore be reviewed rather than relying on a percentage or headline result alone. Available Pure MT2 documentation can be viewed on the laboratory testing analysis page.
Why Product Labels and Batch Information Matter
Unlicensed online products do not have the same regulatory oversight as authorised medicines. Differences may exist between suppliers, batches and individual products, and a label claim is not the same as independent confirmation.
Clear product information should identify the labelled contents, package quantity and supplied components. Where laboratory documentation is published, the report should make it possible to understand which submitted sample or batch the result relates to.
This transparency can help someone assess what is being claimed, but it cannot remove the underlying medical and regulatory uncertainties.
When Should Someone Seek Medical Advice?
Anyone who has used a product containing or claiming to contain Melanotan 2 should seek medical advice if they feel unwell or notice a concerning reaction.
Urgent medical assistance may be needed for symptoms such as difficulty breathing, facial or throat swelling, collapse, severe chest pain, confusion, a seizure or an erection that is painful or does not resolve. In the UK, call 999 in an emergency or contact NHS 111 when urgent advice is needed but the situation is not immediately life-threatening.
Changes to moles or other pigmented skin lesions should be assessed by a GP or dermatologist. It is helpful to explain what product was used, how it was described and when the symptoms or skin changes began.
Suspected adverse effects can also be reported to the MHRA through the Yellow Card scheme. Reporting does not establish that a product caused the event, but it helps regulators identify potential safety signals.
Frequently Asked Questions
Is Melanotan 2 the same as melatonin?
No. Melanotan 2 and melatonin are different substances. Melatonin is a hormone involved in the sleep-wake cycle and is used in licensed medicines for certain sleep conditions. Melanotan 2 is a synthetic melanocortin peptide associated with pigmentation.
Are tanning injections approved in the UK?
No. Melanotan 2 is not authorised by the MHRA as a cosmetic tanning medicine. Availability through a website or social media account does not mean a product is licensed.
Does independent testing mean Melanotan 2 is safe?
No. Testing may provide information about the identity, measured content or reported purity of a submitted sample. It does not establish clinical safety, effectiveness, sterility or regulatory approval unless those matters have been separately and appropriately assessed.
Can Melanotan 2 change freckles or moles?
Darkening of freckles and existing moles has been reported. Published case reports have also described new or atypical-looking pigmented lesions. Any concerning skin change should be checked by a healthcare professional.
Is a nasal spray safer than an injection?
Avoiding an injection removes some injection-specific risks, but it does not prove that a nasal product is safe, effective or reliably absorbed. Neither format is authorised by the MHRA for cosmetic tanning.
Can Melanotan 2 replace sun protection?
No. A darker appearance does not prevent ultraviolet damage. Standard sun-protection measures remain necessary.
A Balanced Summary
Tanning injections usually refer to unlicensed products containing or claiming to contain Melanotan 2. The peptide interacts with melanocortin receptors involved in pigmentation, but its effects are not limited to skin colour and its long-term safety for cosmetic use has not been established.
Melanotan 2 is not an MHRA-authorised tanning medicine in the UK. Reported effects include nausea, flushing, appetite changes, spontaneous erections and changes to freckles or moles. Published case reports have raised additional concerns, although they do not by themselves prove direct causation.
Independent laboratory testing can help verify specific characteristics of a submitted sample, but it does not make a product licensed, clinically proven or risk-free. Anyone considering information about tanning injections should distinguish clearly between laboratory findings, personal reports, marketing claims and regulatory approval.
References and Further Information
- MHRA response concerning side-effect reports for Melanotan II products
- MHRA Yellow Card reporting scheme
- Cancer Research UK: tanning, fake tan and Melanotan
- NHS: melanoma skin cancer
- Pilot phase I study of Melanotan II
- Atypical melanocytic naevi following Melanotan injection
- Melanoma associated with the use of Melanotan II
This article is provided for general information only. It is not medical advice and does not recommend or instruct the use of Melanotan 2. Speak to a qualified healthcare professional for advice about your health.